PMID: 42259339

Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trial.

Welch Michelle, Forst Thomas, Jia Weiping, Del Pino Pedro Orozco, Denning Max, Wu Wen-Shuo, Li Jianghao, Liu Rong, Eifu Michele, Chen Yanyun

Lancet (London, England) · 2026

Vol. 408, Issue 10550, pp. 125-140

This entry links to third-party literature. For research use only.